scholarly article | Q13442814 |
P356 | DOI | 10.1002/CLC.20689 |
P8608 | Fatcat ID | release_hjgd2qgw45d53ei3iepxwqb664 |
P932 | PMC publication ID | 6652986 |
P698 | PubMed publication ID | 20063294 |
P5875 | ResearchGate publication ID | 40900960 |
P2093 | author name string | Li Li | |
Wang Min | |||
Huang Jin-Yu | |||
Huang Shi-Eng | |||
Pei De-An | |||
Xu Zheng-Ming | |||
Xu Zhi-Yun | |||
Yao Qiang | |||
P2860 | cites work | Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated | Q28281477 |
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators | Q28372091 | ||
Mineralocorticoid selectivity: molecular and cellular aspects | Q33888900 | ||
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction | Q34187441 | ||
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial | Q34246898 | ||
Atrial fibrosis and the mechanisms of atrial fibrillation | Q34576855 | ||
The new biology of aldosterone | Q36185968 | ||
11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action | Q36217956 | ||
Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells | Q38330461 | ||
The possible roles of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in cardiac fibrosis in the spontaneously hypertensive rat. | Q38351057 | ||
Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation | Q43777099 | ||
Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study. | Q44064962 | ||
Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials | Q44456364 | ||
Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure | Q44468973 | ||
Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study | Q44672306 | ||
Mineralocorticoid receptor is overexpressed in cardiomyocytes of patients with congestive heart failure | Q45276007 | ||
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study | Q45285131 | ||
Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT). | Q46466522 | ||
Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heart | Q71844423 | ||
Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction | Q78045101 | ||
Mounting evidence that fibrosis generates a major mechanism for atrial fibrillation | Q81432055 | ||
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism | Q81661632 | ||
Selective aldosterone blockade suppresses atrial tachyarrhythmias in heart failure | Q83308267 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Atrial Fibrillation | Q815819 |
hydroxysteroid | Q2157080 | ||
P304 | page(s) | 23-29 | |
P577 | publication date | 2010-01-01 | |
P1433 | published in | Clinical Cardiology | Q4502312 |
P1476 | title | Increased expression of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in human atria during atrial fibrillation | |
P478 | volume | 33 |
Q36494721 | Aldosterone and cardiovascular disease: the heart of the matter |
Q33775560 | Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling |
Q38124345 | Mineralocorticoid receptor and cardiac arrhythmia |
Q37496071 | Structural and Functional Remodeling of the Left Atrium: Clinical and Therapeutic Implications for Atrial Fibrillation |
Q37622571 | The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation |
Search more.